Related references
Note: Only part of the references are listed.A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Yimu Zhao et al.
CELL (2019)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
Claudio de Lucia et al.
FRONTIERS IN PHARMACOLOGY (2018)
Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae
Ingra Mannhardt et al.
TOXICOLOGICAL SCIENCES (2017)
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
Vicente J. Planelles-Herrero et al.
NATURE COMMUNICATIONS (2017)
Calcium Signaling Series
David A. Eisner et al.
CIRCULATION RESEARCH (2017)
WITHDRAWN-a resource for withdrawn and discontinued drugs
Vishal B. Siramshetty et al.
NUCLEIC ACIDS RESEARCH (2016)
Reversible Covalent Binding to Cardiac Troponin C by the Ca2+-Sensitizer Levosimendan
Ian M. Robertson et al.
BIOCHEMISTRY (2016)
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform
Chris Denning et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
Igho J. Onakpoya et al.
CRITICAL REVIEWS IN TOXICOLOGY (2016)
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure The ATOMIC-AHF Study
John R. Teerlink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2016)
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Eric M. Green et al.
SCIENCE (2016)
Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues
Stephanie M. Ravenscroft et al.
TOXICOLOGICAL SCIENCES (2016)
The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat
L. Nagy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
Christiaan C. Veerman et al.
STEM CELLS AND DEVELOPMENT (2015)
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium
Brian D. Guth et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2015)
Pathomechanisms in heart failure: the contractile connection
G. J. M. Stienen
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2015)
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation
Marc N. Hirt et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decisionmaking
Rhian McNaughton et al.
BMJ OPEN (2014)
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes
Donghui Zhang et al.
BIOMATERIALS (2013)
Na/Ca exchange and contraction of the heart
Michela Ottolia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik et al.
SCIENCE (2011)
Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart Failure
You-Tang Shen et al.
CIRCULATION-HEART FAILURE (2010)
L-type Ca2+ current in ventricular cardiomyocytes
Jean-Pierre Benitah et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Calcium cycling and signaling in cardiac myocytes
Donald M. Bers
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Pharmacological inhibition of Na/Ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block
Semir Ozdemir et al.
CIRCULATION RESEARCH (2008)
The inotropic effect of cardioactive glycosides in ventricular myocytes requires Na+-Ca2+ exchanger function
Julio Altamirano et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
The contractile apparatus as a target for drugs against heart failure: Interaction of levosimendan, a calcium sensitiser, with cardiac troponin c
T Sorsa et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Effect of cardiac glycosides on action potential characteristics and contractility in cat ventricular myocytes: Role of calcium overload
SR Ruch et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
An overview of endothelin signaling in the cardiac myocyte
PH Sugden
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Sustained hemodynamic effects of intravenous levosimendan
M Kivikko et al.
CIRCULATION (2003)
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
F Follath et al.
LANCET (2002)
Myocardial efficiency during levosimendan infusion in congestive heart failure
H Ukkonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart -: Studies with an intracoronary ETA receptor antagonist
PA MacCarthy et al.
CIRCULATION (2000)
Share Paper
